Differences
This shows you the differences between two versions of the page.
| Both sides previous revision Previous revision Next revision | Previous revision | ||
|
group_2_presentation_3_-_herpes_simplex_virus [2018/03/30 19:13] yousifcr |
group_2_presentation_3_-_herpes_simplex_virus [2018/03/30 19:59] (current) babadim [Transmission of HSV-1] |
||
|---|---|---|---|
| Line 1: | Line 1: | ||
| + | {{:herpes_simplex_virus_group_2.pdf|}} | ||
| ====== Herpes Simplex Virus ====== | ====== Herpes Simplex Virus ====== | ||
| Line 22: | Line 22: | ||
| ====== Symptoms ====== | ====== Symptoms ====== | ||
| - | **__HSV-1__** <box 30% round right| >{{ :oral-herpes-simplex-virus-infection-pictures.jpg?300|}}</box| Figure 2: Outbreak of herpes sores. (Baugher, 2018)> | + | **HSV-1** <box 30% round right| >{{ :oral-herpes-simplex-virus-infection-pictures.jpg?300|}}</box| Figure 2: Outbreak of herpes sores. (Baugher, 2018)> |
| The primary symptoms of HSV-1 include blisters or open sores around the mouth. Due to these sores, individuals often experience pain and discomfort through symptomatic periods. HSV-1 herpes is highly contagious. Most HSV-1 infections are acquired through childhood. Majority of cases of HSV-1 show symptoms in or around the mouth (sometimes called Orolabial, oral-labial or oral-facial herpes), but some cases show signs around the genitalia, called genital herpes, or anal area. However, the majority of people who are infected with oral HSV-1 show no symptoms, as the infection itself is mostly asymptomatic. However, Symptoms of HSV-1 include painful blisters or open sores called ulcers in or around the mouth. Lesions on the lips are commonly referred to as “cold sores.” an Infected person will often experience a tingling, itching or burning sensation around his/her mouth, before the appearance of sores. After the initial infection, the blisters or ulcers can periodically recur. The frequency of recurrences varies from person to person. HSV-1 can also cause genital herpes in rare episodes. The symptoms can also be mild which include blisters on the genital or anal area or can be asymptomatic as well. In immunocompromised people, such as those with advanced HIV infection, HSV-1 can have more severe symptoms and more frequent recurrences. Rarely, HSV-1 infection can also lead to more severe complications such as encephalitis or keratitis (eye infection) (Herpes simplex virus, 2017). | The primary symptoms of HSV-1 include blisters or open sores around the mouth. Due to these sores, individuals often experience pain and discomfort through symptomatic periods. HSV-1 herpes is highly contagious. Most HSV-1 infections are acquired through childhood. Majority of cases of HSV-1 show symptoms in or around the mouth (sometimes called Orolabial, oral-labial or oral-facial herpes), but some cases show signs around the genitalia, called genital herpes, or anal area. However, the majority of people who are infected with oral HSV-1 show no symptoms, as the infection itself is mostly asymptomatic. However, Symptoms of HSV-1 include painful blisters or open sores called ulcers in or around the mouth. Lesions on the lips are commonly referred to as “cold sores.” an Infected person will often experience a tingling, itching or burning sensation around his/her mouth, before the appearance of sores. After the initial infection, the blisters or ulcers can periodically recur. The frequency of recurrences varies from person to person. HSV-1 can also cause genital herpes in rare episodes. The symptoms can also be mild which include blisters on the genital or anal area or can be asymptomatic as well. In immunocompromised people, such as those with advanced HIV infection, HSV-1 can have more severe symptoms and more frequent recurrences. Rarely, HSV-1 infection can also lead to more severe complications such as encephalitis or keratitis (eye infection) (Herpes simplex virus, 2017). | ||
| - | **__HSV-2__** | + | **HSV-2** |
| It's widespread around the world and is transmitted mainly through sexual intercourse. However, HSV-2 can also be sent through oral sex. The infections that follow HSV-2 are usually severe and incurable. HSV-2 is the leading cause of genital herpes, which can also be caused by herpes simplex virus type 1 (HSV-1) as mentioned earlier. Infection with HSV-2 is lifelong and incurable. Most people are unaware of their infections thinking its some rash on their private areas. An estimate of only 10-20% of people who are infected in HSV-2 reports a prior diagnosis of genital herpes. This also because most of the symptoms are also asymptomatic like in HSV-1 infections. When symptoms do occur, genital herpes is characterized by one or more genital or anal blisters or open sores called ulcers. In addition to genital ulcers, signs of recent infections of HSV-2 often include fever, body aches, and swollen lymph nodes. After an initial genital herpes infection with HSV-2, recurrent symptoms are common but usually less severe than the first outbreak. The frequency of outbreaks tends to decrease over time. People infected with HSV-2 may experience sensations of mild tingling or shoot pain in the legs, hips, and buttocks before the occurrence of genital ulcers (Herpes simplex virus, 2017). | It's widespread around the world and is transmitted mainly through sexual intercourse. However, HSV-2 can also be sent through oral sex. The infections that follow HSV-2 are usually severe and incurable. HSV-2 is the leading cause of genital herpes, which can also be caused by herpes simplex virus type 1 (HSV-1) as mentioned earlier. Infection with HSV-2 is lifelong and incurable. Most people are unaware of their infections thinking its some rash on their private areas. An estimate of only 10-20% of people who are infected in HSV-2 reports a prior diagnosis of genital herpes. This also because most of the symptoms are also asymptomatic like in HSV-1 infections. When symptoms do occur, genital herpes is characterized by one or more genital or anal blisters or open sores called ulcers. In addition to genital ulcers, signs of recent infections of HSV-2 often include fever, body aches, and swollen lymph nodes. After an initial genital herpes infection with HSV-2, recurrent symptoms are common but usually less severe than the first outbreak. The frequency of outbreaks tends to decrease over time. People infected with HSV-2 may experience sensations of mild tingling or shoot pain in the legs, hips, and buttocks before the occurrence of genital ulcers (Herpes simplex virus, 2017). | ||
| Line 36: | Line 36: | ||
| ====== Transmission of HSV-1 ====== | ====== Transmission of HSV-1 ====== | ||
| - | <box 20% round right| >{{ :herpes.jpg?200|}}</box|Figure 4: An individual exhibiting a cold sore caused by HSV-1. (IN TEXT)> | + | <box 20% round right| >{{ :herpes.jpg?200|}}</box|Figure 4: An individual exhibiting a cold sore caused by HSV-1. https://skinpractice.com/best-product-reviews-for-cold-sores/> |
| - | Initial infection with HSV1 is caused by contact with mucosal surfaces or abraded skin (Whitley & Roizman, 2001) in regions such as the lips, mouth, and skin above the waist (Nahmias, Keyserling & Lee, 1989). An individual can be affected with HSV-1 through close nonsexual contact with an affected individual such as kissing (even on the cheek), sharing utensils and sharing drinks, as the virus can remain viable for a brief period of time on skin, clothing and plastics (Fatahzadeh & Schwartz, 2007). An individual is most contagious when they are exhibiting cold sores or lesions, but is still contagious without showing symptoms. | + | Initial infection with HSV-1 is caused by contact with mucosal surfaces or abraded skin (Whitley & Roizman, 2001) in regions such as the lips, mouth, and skin above the waist (Nahmias, Keyserling & Lee, 1989). An individual can be affected with HSV-1 through close nonsexual contact with an affected individual such as kissing (even on the cheek), sharing utensils and sharing drinks, as the virus can remain viable for a brief period of time on skin, clothing and plastics (Fatahzadeh & Schwartz, 2007). An individual is most contagious when they are exhibiting cold sores or lesions, but is still contagious without showing symptoms. |
| HSV-1 invades surfaces through the interaction of cell surface receptors with viral glycoproteins (Heldwein & Krummenacher, 2008). Nectin-1 is a cell adhesion molecule and HVEM is the herpes virus entry mediator that is found on the surface of different cells (Shui & Kronenberg, 2013). Nectin-1 is found on oral epithelium cells and HVEM is expressed in approximately 40% of cells. One or both of these receptors bind with viral glycoproteins, with glycoprotein D being the principle glycoprotein. The virus then invades the epithelium through the basal layer (Thier et al., 2017). | HSV-1 invades surfaces through the interaction of cell surface receptors with viral glycoproteins (Heldwein & Krummenacher, 2008). Nectin-1 is a cell adhesion molecule and HVEM is the herpes virus entry mediator that is found on the surface of different cells (Shui & Kronenberg, 2013). Nectin-1 is found on oral epithelium cells and HVEM is expressed in approximately 40% of cells. One or both of these receptors bind with viral glycoproteins, with glycoprotein D being the principle glycoprotein. The virus then invades the epithelium through the basal layer (Thier et al., 2017). | ||
| Line 80: | Line 80: | ||
| - | The current model for membrane fusion between HSV and the host cell suggests that binding to one of the gD receptors using Nectin-1 (both HSV1 and HSV2) and Nectin-2 (HSV2) induces a conformational change in gD that initiates the fusion between the virus and the host cell. The conformational change activates a multi-glycoprotein complex involving gB, gD, gH, and gL receptors. Once the viral envelope is fused with the cellular membrane, viral and cellular membranes are merged and lipid mixing occurs. This results in the release of the viral nucleocapsid and tegument proteins into the host cell’s cytoplasm. The gB receptor is primarily responsible for this (Figure 8) | + | The current model for membrane fusion between HSV and the host cell suggests that binding to one of the gD receptors using Nectin-1 (both HSV-1 and HSV-2) and Nectin-2 (HSV-2) induces a conformational change in gD that initiates the fusion between the virus and the host cell. The conformational change activates a multi-glycoprotein complex involving gB, gD, gH, and gL receptors. Once the viral envelope is fused with the cellular membrane, viral and cellular membranes are merged and lipid mixing occurs. This results in the release of the viral nucleocapsid and tegument proteins into the host cell’s cytoplasm. The gB receptor is primarily responsible for this (Figure 8) |
| With endocytosis, the enveloped particles through phagocytosis fuse with a vesicular membrane. Using similar interactions between gB, gD, gH, and gL, and host cell receptors, except all in an endosome, facilitate the fusion with host cell membrane. | With endocytosis, the enveloped particles through phagocytosis fuse with a vesicular membrane. Using similar interactions between gB, gD, gH, and gL, and host cell receptors, except all in an endosome, facilitate the fusion with host cell membrane. | ||
| Whether or not the virus using endocytosis or fusion at the plasma membrane is dependent upon individual cell types that they encounter. In Vero and Hep2 infected cells, there is no preference. However, in CHO, HeLa, RPE, human epidermal keratinocytes and KCjE cells, there is a preference for endocytosis. (Akhtar & Shukla, 2009) | Whether or not the virus using endocytosis or fusion at the plasma membrane is dependent upon individual cell types that they encounter. In Vero and Hep2 infected cells, there is no preference. However, in CHO, HeLa, RPE, human epidermal keratinocytes and KCjE cells, there is a preference for endocytosis. (Akhtar & Shukla, 2009) | ||
| - | <box 55% round| >{{ :complex.png?500|}} </box| Figure 9: The molecular interactions that facilitate HSV entry (Akhtar & Shukla, 2009)> | + | <box 45% round| >{{ :complex.png?500|}} </box| Figure 9: The molecular interactions that facilitate HSV entry (Akhtar & Shukla, 2009)> |
| ====== Post Entry Into Host Cell for HSV-1 & HSV-2 ====== | ====== Post Entry Into Host Cell for HSV-1 & HSV-2 ====== | ||
| Line 93: | Line 93: | ||
| ====== Neural Cells Affected by HSV-1 ====== | ====== Neural Cells Affected by HSV-1 ====== | ||
| - | After the virus invades the epithelium and replicates, it travels to the trigeminal ganglia and surrounding sensory neurons in retrograde via nerve termini where the virus will be latent (Nicoll, Proenca, & Efstathiou, 2012). HSV1 can then reactivate due to physical and emotional stress, tissue damage, fever and ultraviolet light (Whitley & Roizman, 2001). During the latent phase, gene expression is suppressed, but increased during the reactivation phase through the expression of lytic cycle genes (Margolis, Imai, Yang, Vallas, & Krause, 2007). As a result, the virus then travels anterograde back to the epithelium producing lesions and sores (Liu, Khanna, Carriere, & Hendricks, 2001). | + | After the virus invades the epithelium and replicates, it travels to the trigeminal ganglia and surrounding sensory neurons in retrograde via nerve termini where the virus will be latent (Nicoll, Proenca, & Efstathiou, 2012). HSV-1 can then reactivate due to physical and emotional stress, tissue damage, fever and ultraviolet light (Whitley & Roizman, 2001). During the latent phase, gene expression is suppressed, but increased during the reactivation phase through the expression of lytic cycle genes (Margolis, Imai, Yang, Vallas, & Krause, 2007). As a result, the virus then travels anterograde back to the epithelium producing lesions and sores (Liu, Khanna, Carriere, & Hendricks, 2001). |
| ====== Neural Cells Affected by HSV-2 ====== | ====== Neural Cells Affected by HSV-2 ====== | ||
| - | <box 35% round right| >{{ :sacral.png?300|}} | + | <box 30% round right| >{{ :sacral.png?300|}} |
| </box| Figure 11: Distribution of the sacral nerve ganglia. (Vassantachart, & Menter, 2016)> | </box| Figure 11: Distribution of the sacral nerve ganglia. (Vassantachart, & Menter, 2016)> | ||
| Line 103: | Line 103: | ||
| </box|Figure 10: The location and presentation of two lumbosacral clusters of vesicles in different stages of development and healing (Vassantachart, & Menter, 2016)> | </box|Figure 10: The location and presentation of two lumbosacral clusters of vesicles in different stages of development and healing (Vassantachart, & Menter, 2016)> | ||
| - | HSV1 and HSV2 are very similar except for differences in site-specific activation of symptoms. | + | HSV-1 and HSV-2 are very similar except for differences in site-specific activation of symptoms. |
| Once the virus has infected the cells, it enters a dormant state and can establish a lifelong latent infection in sensory neurons of the central nervous system that innervate the site of primary, and productive infection. The latency of the virus is important because it forms a reservoir of the virus to produce recurrent infections, disease, and transmission to other individuals. | Once the virus has infected the cells, it enters a dormant state and can establish a lifelong latent infection in sensory neurons of the central nervous system that innervate the site of primary, and productive infection. The latency of the virus is important because it forms a reservoir of the virus to produce recurrent infections, disease, and transmission to other individuals. | ||
| HSV-2 is associated with latent infection in the lumbosacral dorsal root ganglia (DRG), giving rise to the symptoms below the waist and predominantly in the genital area (Figure 10 and 11) (Kramer, Cook, Roth, Khu, Holman, Knipe, & Coen, 2003). | HSV-2 is associated with latent infection in the lumbosacral dorsal root ganglia (DRG), giving rise to the symptoms below the waist and predominantly in the genital area (Figure 10 and 11) (Kramer, Cook, Roth, Khu, Holman, Knipe, & Coen, 2003). | ||
| - | The specific effects that HSV-2 has on these neurons is still under extensive research. However, researchers do know that latent HSV-2 infection changes the gene expression in these neurons and attaches to neurons that are KH10 positive. HSV2 acts by inducing neuronal injury or by inducing a persistent immune response to the latent infection that induces the expression of cytokines which are also known to alter gene expression. Specifically, it can cause an increase of Stat1 in neurons. In addition, studies have shown that altered gene expression causes changes in Gprc1g, Gabbr1, Kcnab2, and Kcnc1 genes, affecting the neuronal excitability in an interconnected manner. The changing of the neuronal physiology alters sensations in this area and the latently infected ganglia exhibit alterations in ion channel functioning, leading to the commonly observed symptoms in the genitals (Kramer, Cook, Roth, Khu, Holman, Knipe, & Coen, 2003). | + | The specific effects that HSV-2 has on these neurons is still under extensive research. However, researchers do know that latent HSV-2 infection changes the gene expression in these neurons and attaches to neurons that are KH10 positive. HSV-2 acts by inducing neuronal injury or by inducing a persistent immune response to the latent infection that induces the expression of cytokines which are also known to alter gene expression. Specifically, it can cause an increase of Stat1 in neurons. In addition, studies have shown that altered gene expression causes changes in Gprc1g, Gabbr1, Kcnab2, and Kcnc1 genes, affecting the neuronal excitability in an interconnected manner. The changing of the neuronal physiology alters sensations in this area and the latently infected ganglia exhibit alterations in ion channel functioning, leading to the commonly observed symptoms in the genitals (Kramer, Cook, Roth, Khu, Holman, Knipe, & Coen, 2003). |
| ====== Crossover between HSV-1 and HSV-2 ====== | ====== Crossover between HSV-1 and HSV-2 ====== | ||
| The difference between the two virus types is in their latency stage. HSV-1 remains dormant in the nerve cells in the neck region, hence the outbursts on the face and mouth. HSV-2 remains dormant in the nerve cells located at the base of the spine, hence the outbursts in the genitals (Pierce, n.d.). Although they differ in where they remain dormant, it is possible and quite common for the viruses to crossover to different regions from the upper body to the lower body, and vice versa. Therefore, HSV-1 can cause genital herpes and HSV-2 can cause oral herpes. HSV-1 can cause genital herpes due to the fact that the lesions of the mouth also undergo the process of “shedding” and during oral sex, come into contact with mucosal membranes, gaining access to entering the body. This can also happen in a reverse fashion. If an individual has HSV-2 and oral sex is performed, the unaffected partner can contract oral herpes by being exposed to HSV-2 due to the same shedding process of the lesions. Therefore, allowing the virus to gain access to mucosal membranes in the mouth area (STDcheck, 2015). | The difference between the two virus types is in their latency stage. HSV-1 remains dormant in the nerve cells in the neck region, hence the outbursts on the face and mouth. HSV-2 remains dormant in the nerve cells located at the base of the spine, hence the outbursts in the genitals (Pierce, n.d.). Although they differ in where they remain dormant, it is possible and quite common for the viruses to crossover to different regions from the upper body to the lower body, and vice versa. Therefore, HSV-1 can cause genital herpes and HSV-2 can cause oral herpes. HSV-1 can cause genital herpes due to the fact that the lesions of the mouth also undergo the process of “shedding” and during oral sex, come into contact with mucosal membranes, gaining access to entering the body. This can also happen in a reverse fashion. If an individual has HSV-2 and oral sex is performed, the unaffected partner can contract oral herpes by being exposed to HSV-2 due to the same shedding process of the lesions. Therefore, allowing the virus to gain access to mucosal membranes in the mouth area (STDcheck, 2015). | ||
| - | In addition, it is important to note that HSV-1 and HSV-2 do invade different neurons - HSV1 being trigeminal ganglia and HSV2 being the lumbosacral dorsal root ganglia. However, HSV-1 is characterized by two different patterns of gene expression. When there is an abundant expression of lytic cycle genes, the HSV-1 virus is infective in some neurons, whereas in other neurons, latency is established. This is all controlled by which neurons express either MAb KH10 (productive infection), or MAb A5 (latent infection). Both of these factors are expressed predominantly on trigeminal ganglia, but also can be found on lumbosacral DSG. In contrast, HSV2 infects KH10-positive neurons which are primarily found in the lumbosacral DSG, but also in the trigeminal ganglia. Nonetheless, these viruses can take advantage of two different biological niches. Therefore, this phenomenon explains why it is possible to have crossovers between the two viruses, as well as why they are able to infect opposite areas of the body (Margolis, Lmai, Yang, Vallas, Krause, 2007). | + | In addition, it is important to note that HSV-1 and HSV-2 do invade different neurons - HSV-1 being trigeminal ganglia and HSV-2 being the lumbosacral dorsal root ganglia. However, HSV-1 is characterized by two different patterns of gene expression. When there is an abundant expression of lytic cycle genes, the HSV-1 virus is infective in some neurons, whereas in other neurons, latency is established. This is all controlled by which neurons express either MAb KH10 (productive infection), or MAb A5 (latent infection). Both of these factors are expressed predominantly on trigeminal ganglia, but also can be found on lumbosacral DSG. In contrast, HSV-2 infects KH10-positive neurons which are primarily found in the lumbosacral DSG, but also in the trigeminal ganglia. Nonetheless, these viruses can take advantage of two different biological niches. Therefore, this phenomenon explains why it is possible to have crossovers between the two viruses, as well as why they are able to infect opposite areas of the body (Margolis, Lmai, Yang, Vallas, Krause, 2007). |
| Line 125: | Line 125: | ||
| <box 20% round left| >{{ :acyclovir.jpg?200|}}</box|Figure 12: Acyclovir Medication for treatment of Herpes Simplex Virus. Brand names include Avirax, and Zovirax (Jane, 2011).> | <box 20% round left| >{{ :acyclovir.jpg?200|}}</box|Figure 12: Acyclovir Medication for treatment of Herpes Simplex Virus. Brand names include Avirax, and Zovirax (Jane, 2011).> | ||
| - | <box 35% round left| >{{ :valacyclovir-hcl.jpg?400|}}</box|Figure 13: Valacyclovir HCl Medication, used for the treatment of Cold Sores (Oral Herpes) and Genital Herpes, as well as Shingles (HSVType 1, 2013).> | + | <box 35% round left| >{{ :valacyclovir-hcl.jpg?380|}}</box|Figure 13: Valacyclovir HCl Medication, used for the treatment of Cold Sores (Oral Herpes) and Genital Herpes, as well as Shingles (HSVType 1, 2013).> |
| <box 30% round left| >{{ :famciclovir.jpg?300|}}</box|Figure 14: Famciclovir Medication is also another treatment option for Genital Herpes, and Shingles (Doktor, 2018).> | <box 30% round left| >{{ :famciclovir.jpg?300|}}</box|Figure 14: Famciclovir Medication is also another treatment option for Genital Herpes, and Shingles (Doktor, 2018).> | ||
| Line 182: | Line 182: | ||
| - | // Recommended Treatments for Suppressive Therapy for Genital Herpes // | + | **Recommended Treatments for Suppressive Therapy for Genital Herpes** |
| - | Acyclovir 400 mg orally twice a day | + | * Acyclovir 400 mg orally twice a day |
| - | OR | + | * Valacyclovir 500 mg orally once a day* |
| + | * Valacyclovir 1 g orally once a day | ||
| + | * Famiciclovir 250 mg orally twice a day | ||
| - | Valacyclovir 500 mg orally once a day* | + | // *Valacyclovir 500 mg once a day may be less effective than other Valacyclovir or Acyclovir dosing treatments in people who have recurrences often (Ex. Greater than or equal to 10 episodes per year) (Centers for Disease Control and Prevention, 2015). // |
| - | OR | + | |
| - | Valacyclovir 1 g orally once a day | + | Episodic treatment however does not reduce the risk for transmitting HSV to as sexual partner like Suppressive Therapy does (Crooks, & Baur, 2014). Episodic Treatment is effective for recurrent genital herpes when the therapy is initiated within a day of lesion onset or during the prodrome that follows the outbreaks. When the symptoms begin, it is important to provide the patient with a supply of drug or a prescription for the medication with the instructions so that they can start their treatment right away (Centers for Disease Control and Prevention, 2015). |
| - | OR | + | |
| - | Famiciclovir 250 mg orally twice a day | + | ** Recommended Treatments for Episodic Treatment for Genital Herpes ** |
| - | // *Valacyclovir 500 mg once a day may be less effective than other Valacyclovir or Acyclovir dosing treatments in people who have recurrences often (Ex. Greater than or equal to 10 episodes per year) (Centers for Disease Control and Prevention, 2015). // | + | Listed below are various recommended treatments (Centers for Disease Control and Prevention, 2015): |
| - | Episodic treatment however does not reduce the risk for transmitting HSV to as sexual partner like Suppressive Therapy does (Crooks, & Baur, 2014). Episodic Treatment is effective for recurrent Genital Herpes when the therapy is initiated within a day of lesion onset or during the prodrome that follows the outbreaks. When the symptoms begin, it is important to provide the patient with a supply of drug or a prescription for the medication with the instructions so that they can start their treatment right away (Centers for Disease Control and Prevention, 2015). | + | * Acyclovir 400 mg orally three times a day for 5 days |
| + | * Acyclovir 800 mg orally twice a day for 5 days | ||
| + | * Acyclovir 800 mg orally three times a day for 2 days | ||
| + | * Valacyclovir 500 mg orally twice a day for 3 days | ||
| + | * Valacyclovir 1 g orally once a day for 5 days | ||
| + | * Famciclovir 125 mg orally twice daily for 5 days | ||
| + | * Famciclovir 1 gram orally twice daily for 1 day | ||
| + | * Famciclovir 500 mg once, followed by 250 mg twice daily for 2 days | ||
| - | // Recommended Treatments for Episodic Treatment for Genital Herpes // | ||
| - | Acyclovir 400 mg orally three times a day for 5 days | + | ** Acyclovir: Mechanism of Action ** |
| - | OR | + | |
| - | Acyclovir 800 mg orally twice a day for 5 days | + | Acyclovir acts to inhibit the viral replication of HSV-1 and HSV-2 (Jane, 2011). It interferes with the synthesis of viral DNA. This reduces the viral shedding and reduces the time for healing of the lesions (Jane, 2011). Acyclovir, is an acyclic purine nucleoside analog that is a very potent inhibitor of Herpes Simplex Virus (HSV) (Elion, 1982). It has a significantly low toxicity for the host cells. The virus code for a viral thymidine kinase that can phosphorylate Acyclovir to a monophosphate form that uninfected cells are not able to do. This causes selectivity by Acyclovir. The monophosphate Acyclovir (acyclo-GMP) is converted to Acyclovir triphosphate (acyclo-GTP) by the virus cells. Acyclo-GTP stays in the HSV-infected cells for hours even after Acyclovir is removed. The amount of acyclo-GTP present in the HSV-infected cells is much greater than in non-infected cells. It is the Acyclo-GTP form of Acyclovir that acts as a potent inhibitor of the viral DNA polymerase in Oral Herpes (HSV-1), and Genital Herpes (HSV-2). Both HSV-1 and HSV-2’s DNA polymerase bind very strongly to the acyclo-GMP-terminated template, and gets inactivated (Elion, 1982). |
| - | OR | + | |
| - | Acyclovir 800 mg orally three times a day for 2 days | + | __Effects of Acyclovir__ |
| - | OR | + | |
| - | Valacyclovir 500 mg orally twice a day for 3 days | + | An experiment done by Elion and team, looked at the activity of acyclo-GTP in viral DNA (Elion, 1982). The replication of Herpes Viruses depend on a virus-specific DNA polymerase that is different than that of cellular DNA polymerase. In this experiment, Elion looked at how a strain of virus that has its own DNA polymerase and its own sensitivity is affected by acyclo-GTP. The activity of DNA polymerase was measured by its ability to include dTTP into an activated DNA template with the presence of dCTP, dATP, and dGTP. It is important to note that Acyclovir had not effect on the rate of reaction, however acyclo-GTP was acting in an inhibitory manner. The reaction rate of the inhibited reaction for the initial 15 minutes was linear. However, at higher concentrations, about 20 microM, the reaction rate of the viral DNA polymerase was decreased and almost ceased. When inhibition constants for each DNA polymerase were calculated for viral and cellular DNA polymerase, it became evident that cellular DNA polymerases were much less sensitive to acyclo-GTP than viral DNA polymerase, proving the selectivity aspect of Acyclovir. These results aided in showing that Acyclovir is selective (Elion, 1982). |
| - | OR | + | |
| - | Valacyclovir 1 g orally once a day for 5 days | + | <box 35% round| >{{ :acyclovir_graph.png?400|}}</box|Figure 15: This image shows the dose response curve of different viruses and cell lines to Acyclovir. HSV-1-CL strain, and HSV-2-MS strain, which were grown in Vero cells, Varicella Zoster Virus (VZV) and human cytomegalovirus (HCMV) were grown in WI 38 cells (Elion, 1982).> |
| - | OR | + | |
| - | Famciclovir 125 mg orally twice daily for 5 days | ||
| - | OR | ||
| - | Famciclovir 1 gram orally twice daily for 1 day | + | The mechanism of action is very similar for Valacyclovir and Famciclovir as well, they both act to inhibit the replication of the viral DNA in the host’s body. |
| - | OR | + | |
| - | Famciclovir 500 mg once, followed by 250 mg twice daily for 2 days (Centers for Disease Control and Prevention, 2015). | ||
| - | ** Acyclovir - Mechanism of Action ** | ||
| - | Acyclovir acts to inhibit the viral replication of HSV-1 and HSV-2 (Jane, 2011). It interferes with the synthesis of viral DNA. This reduces the viral shedding and reduces the time for healing of the lesions (Jane, 2011). Acyclovir, is an acyclic purine nucleoside analog that is a very potent inhibitor of Herpes Simplex Virus (HSV) (Elion, 1982). It has a significantly low toxicity for the host cells. The virus code for a viral thymidine kinase that can phosphorylate Acyclovir to a monophosphate form that uninfected cells are not able to do. This causes selectivity by Acyclovir. The monophosphate Acyclovir (acyclo-GMP) is converted to Acyclovir triphosphate (acyclo-GTP) by the virus cells. Acyclo-GTP stays in the HSV-infected cells for hours even after Acyclovir is removed. The amount of acyclo-GTP present in the HSV-infected cells is much greater than in non-infected cells. It is the Acyclo-GTP form of Acyclovir that acts as a potent inhibitor of the viral DNA polymerase in Oral Herpes (HSV-1), and Genital Herpes (HSV-2). Both HSV-1 and HSV-2’s DNA polymerase bind very strongly to the acyclo-GMP-terminated template, and gets inactivated (Elion, 1982). | + | Other treatments for oral herpes include: |
| - | // Experiment looking at the effects of Acyclovir // | + | * A topical anesthetic such a Lidocaine (Dilocaine, Nervocaine, Xylocaine, Zilactin-L) to relieve pain |
| + | * Oral or IV medication for those with a weakened immune system, infants who are younger than 6 weeks, or those with severe disease | ||
| - | An experiment done by Elion and team, looked at the activity of acyclo-GTP in viral DNA (Elion, 1982). The replication of Herpes Viruses depend on a virus-specific DNA polymerase that is different than that of cellular DNA polymerase. In this experiment, Elion looked at how a strain of virus that has its own DNA polymerase and its own sensitivity is affected by acyclo-GTP. The activity of DNA polymerase was measured by its ability to include dTTP into an activated DNA template with the presence of dCTP, dATP, and dGTP. It is important to note that Acyclovir had not effect on the rate of reaction, however acyclo-GTP was acting in an inhibitory manner. The reaction rate of the inhibited reaction for the initial 15 minutes was linear. However, at higher concentrations, about 20 microM, the reaction rate of the viral DNA polymerase was decreased and almost ceased. When inhibition constants for each DNA polymerase were calculated for viral and cellular DNA polymerase, it became evident that cellular DNA polymerases were much less sensitive to acyclo-GTP than viral DNA polymerase, proving the selectivity aspect of Acyclovir. These results aided in showing that Acyclovir is selective (Elion, 1982). | + | Serious cases may require hospitalization such as: |
| + | * Severe local infection | ||
| + | * Infection which has spread to other parts of the body | ||
| + | * Individuals who have been dehydrated and need IV hydration (DerSarkissian, 2016) | ||
| + | | ||
| - | <box 35% round| >{{ :acyclovir_graph.png?400|}}</box|Figure 15:This image shows the dose response curve of different viruses and cell lines to Acyclovir. HSV-1-CL strain, and HSV-2-MS strain, which were grown in Vero cells, Varicella Zoster Virus (VZV) and human cytomegalovirus (HCMV) were grown in WI 38 cells (Elion, 1982).> | + | ** Management of Genital Herpes ** |
| + | To manage Genital Herpes, there are a number of ways a person can go about doing that (Crooks, & Baur, 2014). This may vary from person to person and it is encouraged that they try different ways to manage the virus. | ||
| - | The mechanism of action is very similar for Valacyclovir and Famciclovir as well, they both act to inhibit the replication of the viral DNA in the host’s body. | + | __Keep blisters dry and clean__ |
| + | This will reduce the chances of secondary infections, shorten the period of viral shedding, and speed up lesion healing. It is important to wash the area of concern with warm water and soap 2-3 times a day. After bathing, it is important to dry the area thoroughly by gently patting it using a soft cotton towel or blow drying the area with a hair dryer that is on Cool. It is important to keep the area dry as mentioned before and so sprinkling the dried area with cornstarch or baby powder can also be helpful. It is recommended to wear loose cotton clothing that does not trap moisture and keeps the area dry. | ||
| + | __Take 2 aspirin every 3 to 4 hours to help reduce the pain and itching__ | ||
| - | Other treatments for Oral Herpes include: | + | Local anaesthetic such as lidocaine jelly, can help to reduce soreness. Ice packs can be applied directly to the area of lesions as it provides temporary relief but it is important to note not to wet the lesions when using an ice pack as ice melts. One can powder the area to reduce and alleviate the itching. |
| - | * A topical anesthetic such a Lidocaine (Dilocaine, Nervocaine, Xylocaine, Zilactin-L) can be used to relieve pain. | + | __Drink lots of fluids__ |
| - | * Oral or IV medication exists but it should only be used for people who have a weakened immune system, infants who are younger than 6 weeks, or people with severe disease. | + | |
| - | * Serious cases may require hospitalization: | + | |
| - | - people with severe local infection | + | |
| - | - People with infection has which has spread to other part of the body | + | |
| - | - People with a weak immune system | + | |
| - | - People who have been dehydrated and need IV hydration | + | |
| - | - Infants who are younger than 6 weeks (DerSarkissian, 2016) | + | |
| - | // Management of Genital Herpes // | + | One of the symptoms some can have is intense burning sensation when urinating if the urine comes in contact with the lesions. This is discomforting and it can be reduced by pouring water over the genitals while urinating or to urinate in a bathtub filled with water. Drink a lot of fluids to help dilute the acid in the urine, but avoid liquids that may cause the urine to become more acidic, such as cranberry juice. |
| - | To manage Genital Herpes, there are a number of ways a person can go about doing that (Crooks, & Baur, 2014). This may vary from person to person and it is encouraged that they try different ways to manage the virus. | + | __Reduce stress__ |
| - | * Keep blisters dry and clean. This will reduce the chances of secondary infections, shorten the period of viral shedding, and speed up lesion healing. It is important to wash the area of concern with warm water and soap 2-3 times a day. After bathing, it is important to dry the area thoroughly by gently patting it using a soft cotton towel or blow drying the area with a hair dryer that is on Cool. It is important to keep the area dry as mentioned before and so sprinkling the dried area with cornstarch or baby powder can also be helpful. It is recommended to wear loose cotton clothing that does not trap moisture and keeps the area dry. | + | |
| - | * It is also known that taking 2 aspirin every 3 to 4 hours may help reduce the pain and itching. Local anaesthetic such as lidocaine jelly, can help to reduce soreness. Ice packs can be applied directly to the area of lesions as it provides temporary relief but it is important to note not to wet the lesions when using an ice pack as ice melts. One can powder the area to reduce and alleviate the itching. | + | It had also been implicated that stress can trigger the recurrence of herpes, and so it is a good idea to reduce negative influence that may be causing stress. To do this, one may try different relaxation techniques, Yoga, or meditations, and using counselling to cope with the daily pressures. |
| - | * One of the symptoms some can have is intense burning sensation when urinating if the urine comes in contact with the lesions. This is discomforting and it can be reduced by pouring water over the genitals while urinating or to urinate in a bathtub filled with water. Drink a lot of fluids to help dilute the acid in the urine, but avoid liquids that may cause the urine to become more acidic, such as cranberry juice. | + | |
| - | * It had also been implicated that stress can trigger the recurrence of herpes, and so it is a good idea to reduce negative influence that may be causing stress. To do this, one may try different relaxation techniques, Yoga, or meditations, and using counselling to cope with the daily pressures. | + | __Recognize common occurrences__ |
| - | * If one is prone to getting recurrent herpes, it may be helpful to record the events that occur right after the outbreak to see if they are able to recognize any common events that occur such as fatigue, stress, or even excessive sunlight. This way, they can avoid such events in the future and reduce the number of relapses of herpes (Crooks, & Baur, 2014). | + | |
| + | If one is prone to getting recurrent herpes, it may be helpful to record the events that occur right after the outbreak to see if they are able to recognize any common events that occur such as fatigue, stress, or even excessive sunlight. This way, they can avoid such events in the future and reduce the number of relapses of herpes (Crooks, & Baur, 2014). | ||
| ** Management for Oral Herpes ** | ** Management for Oral Herpes ** | ||
| - | For the management of Oral Herpes, one can use Acetaminophen (such as Feverall, Panadol, and Tylenol) or Ibuprofen (such as Ibuprin, Advil, and Motrin) for fever and muscle aches as they are some of the symptoms in people who are diagnosed with Oral Herpes (DerSarkissian, 2016). It is also important for people with Oral Herpes to drink plenty of fluids, use the pain medications that as prescribed by the doctor, and watch for signs and symptoms of dehydration (DerSarkissian, 2016). | + | For the management of oral herpes, one can use Acetaminophen (such as Feverall, Panadol, and Tylenol) or Ibuprofen (such as Ibuprin, Advil, and Motrin) for fever and muscle aches as they are some of the symptoms in people who are diagnosed with Oral Herpes. It is also important for people with Oral Herpes to drink plenty of fluids, use the pain medications that as prescribed by the doctor, and watch for signs and symptoms of dehydration (DerSarkissian, 2016). |
| - | //Preventative measures for Oral Herpes (HSV Type 1) // | + | ========= Prevention ========= |
| - | There are some simple preventative measures one can take to avoid getting Oral Herpes in the first place. These include (American Academy of Dermatology, 2018): | + | __Oral Herpes__ |
| - | - Avoid direct physical contact with other people. | + | |
| - | - Do not share items that can pass the virus around, such as towels, silverware, clothing, makeup, cups, and lip-balm. | + | There are some simple preventative measures one can take to avoid getting oral herpes in the first place. These include (American Academy of Dermatology, 2018): |
| - | - Do not engage in oral sex, kissing or any other type of sexual activity during an outbreak of herpes. | + | - Avoiding direct physical contact with others |
| - | - Wash your hands thoroughly. | + | - Not sharing items that can spread the virus around such as towels, silverware, clothing, makeup, cups, and lip-balm |
| + | - Not engaging in oral sex, kissing or any other type of sexual activity during an outbreak | ||
| + | - Washing your hands thoroughly | ||
| - | // Preventative Measures for Genital Herpes (HSV Type 2) // | + | __Genital Herpes__ |
| - | - Avoid having sex with infected partners. | + | - Avoid having sex with infected partners |
| - | - Use a latex condom to lower the risk of spreading the virus if you cannot stay away from infected partners. However, be aware that it is possible to spread the virus it if lies nearby the skin that the condom does not cover. | + | - Use a latex condom to lower the risk of spreading the virus if you cannot stay away from infected partners (however, be aware that it is possible to spread the virus it if lies nearby the skin that the condom does not cover) |
| - | - Also, if you are pregnant, it is important to let your doctor know if you or your partner has Genital Herpes. This is to ensure if you need to take medication after your pregnancy or not so the virus is not passed on to the baby (American Academy of Dermatology, 2018). | + | - If you are pregnant, let your doctor know if you or your partner has genital herpes to take prepare precautions to not transfer the virus to your baby (American Academy of Dermatology, 2018). |
| - | ========= How To Get Tested? ========= | + | |
| - | Many clinics around the world, especially in North America, offer a type-specific blood test for both herpes type 1 and herpes type 2. These blood tests look for antibodies to HSV-1 and HSV-2 in the patient's blood. These tests usually test for genital infections. For instance, HSV-2 that mainly infect the private areas can be detected as early as three weeks after possible exposure. However, it's recommended to wait for between 3-6 to get tested for more accurate results. After three months post-exposure to the virus, getting tested again is advised to eliminate the possibility of recurrent infection. Testing for Herpes Simplex Virus Type 1 (HSV-1) in the blood using the Enzyme-Linked Immunosorbent Assay (ELISA) test. This type-specific HSV-1 blood test looks for antibodies to the HSV-1 virus in the bloodstream. This test is highly sensitive and will only detect the presence of HSV-1 antibodies. Since the HSV-2 virus causes 20% of oral herpes cases, we recommend ordering both the HSV-1 test and HSV-2 test. After taking both tests results will read as either positive (HSV-1 or HSV-2 is found in blood) or negative (no HSV-1 or HSV-2 virus is found in blood) (Genital Herpes Overview, 2018). | + | |
| + | ========= Getting Tested ========= | ||
| + | Many clinics around the world, especially in North America, offer a type-specific blood test for both HSV-1 and HSV-2. These blood tests look for antibodies to HSV-1 and HSV-2 in the patient's blood. These tests usually test for genital infections. For instance, HSV-2 can be detected as early as three weeks after possible exposure. However, it's recommended to wait between 3-6 weeks to get tested for more accurate results. After three months post-exposure to the virus, getting tested again is advised to eliminate the possibility of recurrent infection. Testing for HSV-1 in the blood is done using the Enzyme-Linked Immunosorbent Assay (ELISA) test. This HSV-1 specific blood test looks for antibodies to the HSV-1 virus in the bloodstream. This test is highly sensitive and will only detect the presence of HSV-1 antibodies. Since HSV-2 causes 20% of oral herpes cases, we recommend ordering both the HSV-1 test and HSV-2 test. After taking both tests, results will read as either positive (HSV-1 or HSV-2 is found in blood) or negative (no HSV-1 or HSV-2 virus is found in blood) (Genital Herpes Overview, 2018). | ||
| - | ========= Where is treatment avaialable? ========= | ||
| - | At your local pharmacy, Rexall and even online! | + | ========= Where is Treatment Available? ========= |
| - | Specifically, in Hamilton, there are Health Units that are available that provide services related to the testing of STIs, information of STIs, etc.. | + | Treatment is available at your local pharmacy and even online. In Hamilton specifically there are health units that provide services related to the testing of STIs, information of STIs, etc.. |
| Line 292: | Line 291: | ||
| <box 65% round| >{{ :hamilton_services_page_3.png?700 |}}</box|Figure 18: This is a list of some of the Health Units that are available in Hamilton, Ontario (Hamilton, 2018).> | <box 65% round| >{{ :hamilton_services_page_3.png?700 |}}</box|Figure 18: This is a list of some of the Health Units that are available in Hamilton, Ontario (Hamilton, 2018).> | ||
| + | |||
| + | |||
| + | ========= Conclusion ========= | ||
| + | |||
| + | HSV-1 and HSV-2 most commonly infect humans. HSV-1 predominantly affects regions above the waist as the virus binds to A5 and KH10 receptors on the trigeminal ganglia located in the brain. HSV-2 predominantly affects regions below the waist as the virus binds to the KH10 receptors that are in abundance in the lumbosacral root ganglia located the base of the spine. Crossover between the two types occurs as well due to both ganglia having the KH10 receptor. Although HSV is not curable, there are numerous treatment options, with episodic and suppressive therapies being two in particular. | ||
| ========= References ========= | ========= References ========= | ||
